Cervical Intraepithelial Neoplasia (CIN)
8
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection
Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs
Quality Control of Colposcopy Application
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
Correlation Between Selenium Levels in Human Tissues and HPV-related Cervical Lesions and Outcomes
Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls